NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
07/03/2021
Back to search
Official data from USPTO
NOROMYCIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
07/03/2021
Trademark type
Word
Nice classes
5
Filing date
06/21/2010
Registration date
03/27/2012
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/03/2021
Last transaction
07/03/2021
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
06/10/2008
First use in commerce
06/10/2008
Drawing code
4
Owner type
99
Owner location
Newry, County Down, GB
Examiner
HETZEL, DANNEAN
Law office
L60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Norbrook Laboratories Limited
Representatives
Christopher A. Mitchell, Esq. Dickinson Wright PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and veterinary preparations and substancesantibiotics
Publications
History of USPTO decisions and trademark events.
46 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
07/03/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
07/03/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/03/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
03/29/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/27/2021
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/30/2017
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/30/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/30/2017
E815
TEAS SECTION 8 & 15 RECEIVED
08/31/2017
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/27/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
03/27/2012
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/23/2012
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
02/22/2012
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/21/2012
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/18/2012
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/17/2012
EX1G
SOU EXTENSION 1 GRANTED
02/17/2012
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/17/2012
IUAF
USE AMENDMENT FILED
01/24/2012
EXT1
SOU EXTENSION 1 FILED
01/24/2012
EEXT
SOU TEAS EXTENSION RECEIVED
01/24/2012
EISU
TEAS STATEMENT OF USE RECEIVED
01/24/2012
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/03/2011
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
07/26/2011
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/20/2011
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/31/2011
PUBO
PUBLISHED FOR OPPOSITION
05/31/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/28/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/25/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/22/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/22/2011
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/22/2011
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/01/2011
GNFR
FINAL REFUSAL E-MAILED
04/01/2011
CNFR
FINAL REFUSAL WRITTEN
04/01/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/22/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/22/2011
ALIE
ASSIGNED TO LIE
03/22/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/10/2011
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/04/2010
GNRT
NON-FINAL ACTION E-MAILED
10/04/2010
CNRT
NON-FINAL ACTION WRITTEN
10/04/2010
DOCK
ASSIGNED TO EXAMINER
09/27/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/24/2010
NWAP
NEW APPLICATION ENTERED
06/24/2010
Continuous trademark protection
Get notified about every new filing that threatens NOROMYCIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.